Aarti Drugs has received approval to buyback up to 2,82,100 fully paid-up equity shares of face value of Rs 10 each of the Company representing up to 1.20% of the total number of equity Shares of the company at a price of Rs 900 per Equity Share payable in cash for an aggregate amount of up to Rs 25.38 crore.
The Board of Directors of the Company at its meeting held on March 15, 2019 has approved the same.
Aarti Drugs is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals.
